CL2004001262A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES LAMIVUDINE, ZIDOVUDINA AND EFAVIRENZ, OR DERIVATIVES OF THEM; PHARMACEUTICAL KIT; PROCEDURE FOR PREPARATION; AND USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTIONS, AND - Google Patents
PHARMACEUTICAL COMPOSITION THAT INCLUDES LAMIVUDINE, ZIDOVUDINA AND EFAVIRENZ, OR DERIVATIVES OF THEM; PHARMACEUTICAL KIT; PROCEDURE FOR PREPARATION; AND USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTIONS, ANDInfo
- Publication number
- CL2004001262A1 CL2004001262A1 CL200401262A CL2004001262A CL2004001262A1 CL 2004001262 A1 CL2004001262 A1 CL 2004001262A1 CL 200401262 A CL200401262 A CL 200401262A CL 2004001262 A CL2004001262 A CL 2004001262A CL 2004001262 A1 CL2004001262 A1 CL 2004001262A1
- Authority
- CL
- Chile
- Prior art keywords
- preparation
- zidovudina
- efavirenz
- prevention
- derivatives
- Prior art date
Links
- XPOQHMRABVBWPR-UHFFFAOYSA-N Efavirenz Natural products O1C(=O)NC2=CC=C(Cl)C=C2C1(C(F)(F)F)C#CC1CC1 XPOQHMRABVBWPR-UHFFFAOYSA-N 0.000 title 1
- 208000036142 Viral infection Diseases 0.000 title 1
- XPOQHMRABVBWPR-ZDUSSCGKSA-N efavirenz Chemical compound C([C@]1(C2=CC(Cl)=CC=C2NC(=O)O1)C(F)(F)F)#CC1CC1 XPOQHMRABVBWPR-ZDUSSCGKSA-N 0.000 title 1
- 229960003804 efavirenz Drugs 0.000 title 1
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 title 1
- 229960001627 lamivudine Drugs 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0308603A GB2400552A (en) | 2003-04-14 | 2003-04-14 | Pharmaceutical combinations for treating viral infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2004001262A1 true CL2004001262A1 (en) | 2005-05-06 |
Family
ID=9956763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200401262A CL2004001262A1 (en) | 2003-04-14 | 2004-05-25 | PHARMACEUTICAL COMPOSITION THAT INCLUDES LAMIVUDINE, ZIDOVUDINA AND EFAVIRENZ, OR DERIVATIVES OF THEM; PHARMACEUTICAL KIT; PROCEDURE FOR PREPARATION; AND USE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF VIRAL INFECTIONS, AND |
Country Status (3)
| Country | Link |
|---|---|
| CL (1) | CL2004001262A1 (en) |
| GB (1) | GB2400552A (en) |
| WO (1) | WO2004089382A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110104267A1 (en) * | 2005-04-25 | 2011-05-05 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| JP2020529461A (en) * | 2017-08-09 | 2020-10-08 | ヴィーブ ヘルスケア カンパニー | Combinations and their use and treatment |
| JP2020530024A (en) * | 2017-08-09 | 2020-10-15 | ヴィーブ ヘルスケア カンパニー | Combinations and their use and treatment |
| CN114392239B (en) * | 2022-01-10 | 2023-06-27 | 安徽贝克生物制药有限公司 | Compound tablet of lamivudine, zidovudine and efavirenz and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050070489A1 (en) * | 2001-12-14 | 2005-03-31 | Carter William A | Use of dsrnas in strategic therapeutic intervention of highly active antiretroviral therapy |
-
2003
- 2003-04-14 GB GB0308603A patent/GB2400552A/en not_active Withdrawn
-
2004
- 2004-04-14 WO PCT/GB2004/001612 patent/WO2004089382A1/en not_active Ceased
- 2004-05-25 CL CL200401262A patent/CL2004001262A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB0308603D0 (en) | 2003-05-21 |
| GB2400552A (en) | 2004-10-20 |
| WO2004089382A1 (en) | 2004-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0615157A2 (en) | compound, pharmaceutical composition, methods for inhibiting viral replication in a human patient, and for treating a viral infection in a human patient, and use of a compound | |
| IL171683A (en) | Immunosuppressant compounds, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy | |
| IL163894A (en) | 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments | |
| IL221770A (en) | Adamantyl-acetamide derivatives, pharmaceutical compositions comprising same and use thereof for preparation of medicaments | |
| EE05643B1 (en) | Xanthine derivatives, their preparation and use as medicaments | |
| CL2007003685A1 (en) | COMPOUNDS DERIVED FROM INDOL WITH A UNITED RING IN POSITIONS 4 AND 5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A VIRAL INFECTION. | |
| CL2007003684A1 (en) | COMPOUNDS DERIVED FROM INDOL WITH A UNITED RING IN POSITIONS 5 AND 6; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A VIRAL INFECTION. | |
| BRPI0206509B8 (en) | process for formulating, for parenteral administration, an epothilone analogue, pharmaceutical preparation, process for forming a pharmaceutical composition for parental administration, pharmaceutical composition and use of an epothilone analogue in the preparation of a pharmaceutical composition for the treatment of cancer | |
| ECSP088296A (en) | THERAPEUTIC COMPOUNDS | |
| IL169818A0 (en) | Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them | |
| CL2004000930A1 (en) | COMPOUND DERIVED FROM DEFINED FORMULA DIHYDROQUINAZOLINE, USEFUL FOR THE TREATMENT AND / OR PROFILAXIS OF VIRAL INFECTIONS; PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMPOUND AND USE OF THE COMPOUND IN THE PREPARATION OF MEDICINES. | |
| IL169647A (en) | Hiv replication inhibiting pyrimidines, their use in the preparation of pharmaceutical compositions and pharmaceutical compositions comprising them | |
| ECSP045171A (en) | DOSAGE REGIME AND PHARMACEUTICAL COMPOSITION FOR EMERGENCY ANTI-CONCEPT | |
| ITMI20031570A1 (en) | COMPOSITION FOR DIETARY, PHARMACEUTICAL OR COSMETIC USE | |
| BR0112962B1 (en) | Pharmaceutical compositions comprising hyaluronic acid, glycyrretinic acid and polyvinylpyrrolidone, and their use in the preparation of medicaments. | |
| EE200300327A (en) | Urea derivatives, processes for their preparation, use and pharmaceutical composition | |
| IL162765A (en) | Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use | |
| ECSP055701A (en) | NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME | |
| CL2007002619A1 (en) | COMPOUNDS DERIVED FROM 3-AZA-BICICLO [4.1.0] HEPTANO; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DEPRESSION. | |
| AR028023A1 (en) | A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERLIPIDEMIA AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF MEDICINES | |
| CL2004001012A1 (en) | COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS | |
| NO20035602D0 (en) | A composition comprising a PDE-4 inhibitor and H1 receptor antagonist, as well as its use in the preparation of a medicament for the treatment of respiratory diseases. | |
| ITRM20030363A1 (en) | COMPOSITIONS INCLUDING 3THIODOTYRONIN AND PHARMACEUTICAL USE OF THEM. | |
| BR0208566B1 (en) | Beta-Carboline Derivatives, Their Use, and Pharmaceutical Composition | |
| CL2004001068A1 (en) | COMPOUNDS DERIVED FROM 2,3,4,5-TETRAHYDROBENZO [F] [1,4] OXAZEPINA; PREPARATION PROCEDURES; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF ALZHEIMER'S DISEASE. |